Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
09/19/2012 | CN102670618A Application of spiclomazine and anti-pancreatic cancer pharmaceutical preparation |
09/19/2012 | CN102670617A Application of ibuprofen 2-(2-arylmorpholine-4-yl) ethyl ester in preparation of antidepressant drugs |
09/19/2012 | CN102670616A Novel diclazuril preparation and preparation method thereof |
09/19/2012 | CN102670615A Application of 6-benzyl aminopurine compound in terms of preparation of composition for suppressing oxidative injury to brain tissues |
09/19/2012 | CN102670614A Application of compound 6-benzylaminopurine (BA) in preparation of composition for inhibiting oxidative damage of hepatic tissues |
09/19/2012 | CN102670613A Medicine composition for improving dissolution of indiplon and preparation method of medicine composition |
09/19/2012 | CN102670612A Application of SBT in preventing and treating diabetes mellitus vessel and neuropathy |
09/19/2012 | CN102670611A Vascular targeting embolism sustained release agent of triple compound microsphere for antituberculosis drug, preparation method and applications thereof |
09/19/2012 | CN102670610A Analgesic composition comprising buprenorphine and naltrexone |
09/19/2012 | CN102670609A Compound preparation for treating chronic obstructive pulmonary disease |
09/19/2012 | CN102670608A Ambroxol hydrochloride freeze-dried powder composite used for injection and preparation method thereof |
09/19/2012 | CN102670607A Compound ambroxol hydrochloride composition and preparation method thereof |
09/19/2012 | CN102670606A Application of combination of taurine and acotinic acid for preparation of anti-fibrosis drugs |
09/19/2012 | CN102670605A Method of inhibiting C-KIT kinase |
09/19/2012 | CN102670604A Composition containing candesartan and amlodipine, preparation process, testing process and application thereof |
09/19/2012 | CN102670603A Oral tablet containing candesartan cilexetil and benzene sulfonate amlodipine and preparation method for oral tablet |
09/19/2012 | CN102670602A Solid preparation containing amlodipine and valsartan |
09/19/2012 | CN102670601A Medicinal composition for treating hypertension and medicament box |
09/19/2012 | CN102670600A Medicinal product for inhibiting scar and promoting wound healing, and preparation method and application of medicinal product |
09/19/2012 | CN102670599A Anti-asthma small molecular medicament |
09/19/2012 | CN102670598A Penicillin borneol composition |
09/19/2012 | CN102670597A Application of 5-(4-hydroxyl-3-methoxybenzylidene)rhodanine to preparation of medicament for treating Parkinson's disease |
09/19/2012 | CN102670596A Application of amidine compound |
09/19/2012 | CN102670595A Application of amide compound |
09/19/2012 | CN102670594A Appliance of 4bit-1H-1,2,3- triazole-Beta-lactam derivatives for resisting liver cancer |
09/19/2012 | CN102670593A Indometacin and albuterol suppository, preparation method, detection method and application thereof |
09/19/2012 | CN102670592A Motherwort alkaloid and choline medicinal composition |
09/19/2012 | CN102670591A Composition comprising NO donor and dithiolane and its use for improvement of sexual function |
09/19/2012 | CN102670590A Application of benzamide compound |
09/19/2012 | CN102670589A Application of amide compound |
09/19/2012 | CN102670588A Application of ellagic acid to preparation of antiviral medicament |
09/19/2012 | CN102670587A Application of 7-methoxy-8-isopentenycoumarin in medicine |
09/19/2012 | CN102670586A Application of bilobalide in preparing medicine for treating ischemic cardiomyopathy |
09/19/2012 | CN102670585A Application of bavachinin for resisting asthma |
09/19/2012 | CN102670584A Application of gallocatechin gallate in preparation of benign prostatic hyperplasia resistant medicament |
09/19/2012 | CN102670583A Application of flavonoids in moldavica dragonhead in the preparation of myocardial ischemic antagonist |
09/19/2012 | CN102670582A Inhibitory activity of norathyriol to protein tyrosine phosphatase 1B (PTP1B) and application thereof |
09/19/2012 | CN102670581A Application of alpha-mangostin for prevention and treatment of diabetes mellitus |
09/19/2012 | CN102670580A Preparation method for naftidrofuryl stereoisomer and medicine application |
09/19/2012 | CN102670579A Paclitaxel pharmaceutical composition and preparation method thereof |
09/19/2012 | CN102670578A Application of protosappanin B in preparation of bladder cancer resistant perfusion fluid |
09/19/2012 | CN102670577A Photo-sensitizer composition, and using method and application thereof |
09/19/2012 | CN102670576A Application of pigeon pea ketonic acid A in terms of preparation of medicines for accompanied diseases of diabetes mellitus and hyperlipidaemia |
09/19/2012 | CN102670575A Ketoprofen osmotic pump type controlled release preparation and preparation method thereof |
09/19/2012 | CN102670574A Application of curcumin in preparing medicine for treating intestinal ischemia reperfusion injury |
09/19/2012 | CN102670573A Application of curcumin derivative in preparation of drug for treating prostate cancer disease |
09/19/2012 | CN102670572A Synthesis and application of bis(2,3-dibromo-4,5-dihydroxybenzyl) ether |
09/19/2012 | CN102670571A Novel quinoline compound, and composition containing centipede extract or compounds isolated therefrom for prevention and treatment of cardiovascular disease |
09/19/2012 | CN102670570A Microporous spongy ondansetron hydrochloride film agent and preparation method thereof |
09/19/2012 | CN102670569A Method for preparing absorbable minocyline drug diaphragm |
09/19/2012 | CN102670565A Percutaneous absorption patch containing natural medicaments |
09/19/2012 | CN102670564A Preparation method for nimodipine sustained-release pellet capsule |
09/19/2012 | CN102670561A Vaginal effervescent tablet with biological adhesiveness and preparation process thereof |
09/19/2012 | CN102670560A Losartan potassium osmotic pump controlled release tablet |
09/19/2012 | CN102670559A Salbutamol sulfate osmotic pump type controlled release tablet |
09/19/2012 | CN102670558A Paliperidone osmotic pump controlled-release tablet |
09/19/2012 | CN102670557A Lovastatin osmotic pump controlled release tablet |
09/19/2012 | CN102670556A Tacrolimus osmotic pump type controlled release tablet |
09/19/2012 | CN102670555A Metoprolol fumarate osmotic pump controlled release tablet |
09/19/2012 | CN102670554A Pseudoephedrine hydrochloride osmotic pump controlled release tablet |
09/19/2012 | CN102670553A Venlafaxine hydrochloride osmotic pump controlled release tablet |
09/19/2012 | CN102670552A Vincamine osmotic pump type controlled release tablets |
09/19/2012 | CN102670551A Felodipine osmotic pump controlled release tablet |
09/19/2012 | CN102670550A Pramipexole dihydrochloride osmotic pump type controlled release tablets |
09/19/2012 | CN102670549A Ropinirole hydrochloride osmotic pump type controlled release tablet |
09/19/2012 | CN102670548A Paroxetine hydrochloride osmotic pump type enteric controlled release tablet |
09/19/2012 | CN102670547A Tolterodine tartrate osmotic pump controlled release tablet |
09/19/2012 | CN102670546A Tamsulosin hydrochloride osmotic pump controlled-release tablet |
09/19/2012 | CN102670545A Carvedilol push-pull osmotic pump type controlled release preparation and preparation method thereof |
09/19/2012 | CN102670544A Lacosamide sustained-release tablets and preparation method thereof |
09/19/2012 | CN102670543A Osmotic pump isosorbide mononitrate quick-controlled release tablet |
09/19/2012 | CN102670542A Tramadol hydrochloride osmotic pump controlled release tablet |
09/19/2012 | CN102670541A Hydrochloride sinomenine composition and preparation method of hydrochloride sinomenine composition |
09/19/2012 | CN102670540A Verapamil hydrochloride osmotic pump type controlled release tablet |
09/19/2012 | CN102670539A Metoprolol succinate osmotic pump controlled release tablet |
09/19/2012 | CN102670538A Isosorbide mononitrate osmotic pump controlled release tablets |
09/19/2012 | CN102670537A Trimetazidine dihydrochloride sustained release tablet and preparation method thereof |
09/19/2012 | CN102670536A Method for preparing cefixime dispersible tablets |
09/19/2012 | CN102670535A Clopidogrel hydrochloride tablet |
09/19/2012 | CN102670534A Levamlodipine besylate tablets |
09/19/2012 | CN102670533A Stable aripiprazole orally-disintegrating tablets and preparation method thereof |
09/19/2012 | CN102670532A Iloperidone medicine composition and preparation method thereof |
09/19/2012 | CN102670531A Loxoprofen sodium composition |
09/19/2012 | CN102670530A Formulations of quinolinones |
09/19/2012 | CN102670529A Levo-pantoprazole sodium freeze-dried powder composition for injection and preparation method thereof |
09/19/2012 | CN102670528A Pantoprazole sodium lyophilized powder composition for injection and preparation method thereof |
09/19/2012 | CN102670527A Freeze-dried powder injection of L-oxiracetam and process for preparing freeze-dried powder injection |
09/19/2012 | CN102670526A Oxaliplatin freeze-dried powder injection and preparation method thereof |
09/19/2012 | CN102670525A Application of ursolic-acid nano medicine-carrying microspheres for treating tumors and preparation |
09/19/2012 | CN102670524A Pantoprazole sodium freeze-dried preparation for injection and preparation method thereof |
09/19/2012 | CN102670521A Esomeprazole magnesium enteric-coated pellet and preparation method thereof |
09/19/2012 | CN102670519A Quickly-dissolvable dienogest oral preparation and preparation method thereof |
09/19/2012 | CN102670517A Method for preparing galactosyl chitosan/5-fluorouracil nanoparticle |
09/19/2012 | CN102670516A Tilmicosin soluble powder and preparation method thereof |
09/19/2012 | CN102670515A Andrographolide inclusion compound and preparation process thereof |
09/19/2012 | CN102670514A Agomelatine solid preparation |
09/19/2012 | CN102670513A Ofloxacin molecular inclusion nanometer preparation and preparation method thereof |
09/19/2012 | CN102670512A Sonodynamic liposomal material, preparation method and application thereof in preparing pharmorubicin composite liposomal |
09/19/2012 | CN102670510A Tripterine nanostructure lipid carrier modified by lentiviral vector and appliance for preparing and treating prostatic cancer, lung cancer and breast cancer drug |
09/19/2012 | CN102670509A Lipid preparation containing insoluble camptothecin drug and preparation method thereof |